Protocol I8B-MC-ITRN A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination with Insulin Glargine or Insulin Degludec in Adults with Type 2 Diabetes
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Insulin lispro (Primary) ; Insulin degludec; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PRONTO-T2D
- Sponsors Eli Lilly
- 19 Feb 2018 Planned End Date changed from 15 Feb 2019 to 1 Jan 2019.
- 19 Feb 2018 Planned primary completion date changed from 31 Aug 2018 to 1 Aug 2018.
- 26 Jul 2017 Status changed from not yet recruiting to recruiting.